Song X. Targeting of both PI3K/Akt/mTOR pathway and mutant EGFR to overcome resistance to tyrosine kinase inhibitors in mutant EGFR-mediated lung cancer. OR [Internet]. 2013 Nov. 1 [cited 2026 Oct. 31];1(1):pp.13-19. Available from: https://vripress.com/OR/article/view/81